June 24, 2019
Institute of Human Virology
Chief Communications & Public Affairs Officer
(443) 823-0613 (phone)
(410) 706-1952 (fax)
Wednesday, January 18, 2023
BBC: The scientist who smuggled HIV in her bag into her country to study it and save lives
Acquired immune deficiency syndrome, AIDS, had been recognized as a new disease in 1981, when an increasing number of young homosexuals died of unusual infections and rare cancers. It was also known to affect intravenous drug users and some were known to have contracted it through blood transfusions.
Friday, January 06, 2023
USA Today: Fact check: Research proves HIV is the cause of AIDS, contrary to viral claim
The claim: There is no proof HIV is the cause of AIDS. A Dec. 15 Facebook video shows Kary Mullis, a scientist known for denying the link between HIV and AIDS, claiming again there is no proof HIV is the cause of AIDS. The post was shared more than 1,000 times in a week. The clip comes from a 2009 documentary that promoted AIDS denialism, which has more than 300,000 views on YouTube.
Wednesday, December 21, 2022
Lead Stories: Fact Check: Doctor Did NOT Say On Video That He Manufactured AIDS As Bio Weapon -- This Is A Soviet-Era Disinformation Hoax
Did an American doctor admit on video that he created the HIV and AIDS viruses in a U.S. military medical laboratory, Fort Detrick, so that they could be used as biological weapons for depopulating the world? No, that's not true: Dr. Robert Gallo, the doctor featured in the video, makes no such admission in the footage, and told Lead Stories that his scientific work was not part of any plan to weaponize HIV/AIDS. Historical records show that the claim is a well-documented hoax that dates to a Soviet disinformation campaign from the 1980s.
Thursday, December 01, 2022
Everyday Health: 10 Facts About HIV/AIDS Everyone Should Know
A basic understanding of HIV and AIDS can help dispel the myths, erase stigma, prevent virus transmission, and save lives — beginning with your own.
Monday, October 31, 2022
NCI Grants Awarded to IHV to Prevent Cancer and Improve Screening in Sub-Saharan Africa
Institute of Human Virology (IHV) researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health’s National Cancer Institute (NCI) for a total of $7.5 million. One award aims to reduce the incidence of lung cancer and other cancers associated with using tobacco in Botswana. The other is focusing on improving screening and treatment of anal precancer in Nigeria. Both grants will make use of existing HIV treatment and prevention infrastructure in low- and middle-income countries to reach people living with HIV who are most at risk for these particular types of cancers.
Wednesday, September 28, 2022
TheBody: What Is HIV Remission?
A cure for HIV remains elusive, but one word that is commonly heard is “remission.” Even though it doesn’t mean eradication of the virus, remission is a good thing. But what exactly is remission? Can HIV go into remission? And how does it differ from a cure? Generally, remission means that a disease has stopped being active but hasn’t necessarily been eliminated.
Monday, September 19, 2022
TheBody: HIV Seroconversion: Timeline, Symptoms, Testing, and Treatment
There are several stages of HIV infection—from the initial exposure to the virus to the development of AIDS—but a lot of important changes happen during the earliest stage: seroconversion. So, exactly what is HIV seroconversion? It is the stage in which the immune system first starts to make antibodies to try to fight HIV after exposure. Once detectable levels of antibodies are produced, this is described as seroconversion.
Monday, September 19, 2022
TheBody: What Are the Chances of Getting HIV from One Exposure?
You had a one-night stand with someone of questionable HIV status. Now the panic begins. Could you have HIV after only one exposure? What are the odds?
Tuesday, July 19, 2022
Six-Country African Study Shows COVID-19 Can Be Dangerous in Pregnancy
A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine’s (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.
Thursday, June 23, 2022
New Research Shows Mothers’ HIV Status, Breastfeeding, and the Infant Gut Microbiome Can Have Long-Term Impact on Infant Health
Babies born to women with HIV often have poorer health and under-developed growth in the early months of life than infants born to women without the infection — even if those babies don’t contract HIV during birth, according to a new study by researchers at the University of Maryland School of Medicine (UMSOM)’s Institute for Genome Sciences (IGS) and Institute of Human Virology (IHV). The study also provides new insights into why these health issues often continue throughout the babies’ lives.
Tuesday, May 31, 2022
Medscape: Fatigue Affects Cognitive Processing Speed in the Aging HIV Population
Successful aging is something that most of us strive for. But with aging comes a pervasive condition called fatigue that, in many older adults, interferes with everyday functioning, mental health, social support, and overall quality of life. The relationship between fatigue and cognitive and functional impairment is one of particular interest in people living with HIV (PWH), a patient population that is disproportionately affected but whose lifespan now matches that of the general population.
Wednesday, May 25, 2022
NIH Awards Grant to Train Global Health Scientists in Low-and-Middle-Income Countries
Researchers at the University of Maryland School of Medicine (UMSOM) received a $5.5 million award from the National Institute of Health’s Fogarty International Center to help foster the next generation of global health scientists. The award entitled, “Integrated Network of Scholars in Global Health Research Training (INSIGHT)” will expand global health research across sub-Saharan Africa, South Asia, Latin America, and the Caribbean by providing one-year mentored research training to U.S. and lower-middle income country scholars.
Friday, May 20, 2022
NIH Grant Awarded to Study HIV Drug-Resistant Genetic Mutations Across Africa
University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV) researchers received funding from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for $2.7 million to study genetic changes in two genes from the HIV-1 virus that may make it resistant to antiretroviral therapy. The study, named INSPIRE, will analyze genetic variation in types of HIV circulating in a handful of African countries that will help to better understand the implications of these mutations and will improve clinical management of patients.
Tuesday, May 10, 2022
Medscape: Decentralizing PrEP Offers a Roadmap for Retention
Good solutions have great roadmaps. For HIV preexposure prophylaxis (PrEP), the road map might just be that of contraceptive care. Once an onerous process, over time contraceptive care exploded into a range of options across a broad landscape in terms of approach and accessibility. How then do organizations help vulnerable patients navigate their PrEP journeys using the contraceptive roadmap as a guide?
Friday, March 18, 2022
Deutsche Presse-Agentur: Virus hunt for decades: US researcher Robert Gallo turns 85
Few scientists in the world can come up with as many successes as Robert Gallo: The US researcher was involved in the discovery of the AIDS virus, found leukemia pathogens and other deadly viruses. Now he is 85 - and works even harder than before.
Thursday, March 10, 2022
Healthline: HIV-1 May Be More Virulent When Transmitted Through Penile-Vaginal Intercourse
HIV-1 can be transmitted through vaginal, anal, and oral sex, whether it’s with a same-sex or different-sex partner. But the risk of developing it seems to vary depending on how the disease is transmitted. In fact, the HIV virus may be more virulent when passed between male and female partners who have penile-vaginal sex than among men who have anal sex with other men, according to a new study from the Indian Institute of Science.
Thursday, March 10, 2022
HIV Plus: One Woman Shares Her Journey of Living with HIV for Over Three Decades
In honoring long-term survivors and National Women and Girls HIV Awareness Day on March 10, I had the opportunity to speak with Ms. Kathy Bennett. She is a 63-year-old Black woman who has been living with HIV for over 31 years. She recently led the longest running HIV support group in Maryland.
Wednesday, February 16, 2022
WBAL: Maryland HIV researcher on latest research: It's not a cure
Scientists used a cutting-edge stem cell transplant method to treat a woman's HIV, but a lead researcher in Maryland said it's too soon to celebrate. A U.S. woman is the third known person who is in HIV remission after receiving stem cells from umbilical cord blood, an American research team announced Wednesday.
Monday, February 07, 2022
The GW Hatchet: University administers first doses of mRNA HIV vaccine through Moderna partnership
GW was one of the first institutions in the country to administer doses of the first mRNA HIV vaccines to human test subjects late last month. The School of Medicine and Health Sciences and its Vaccine Research Unit collaborated with Moderna to test the safety of the vaccine and the immune responses of two participants in the phase 1 clinical trial.
Friday, February 04, 2022
WYPR: How the COVID pandemic rattled HIV testing
The COVID pandemic did not end the HIV-AIDS epidemic; it may have obscured it for a while, raising hurdles to getting tested for HIV.
Wednesday, January 26, 2022
STAT: Early research suggests cancer drug could help flush HIV from its hiding spots
In a study published Wednesday in Science Translational Medicine, researchers looked at 32 patients that had both cancer and HIV and found that pembrolizumab, which revives the immune system and encourages it to attack tumors, also has the ability to flush HIV out of its hiding spot in immune cells.
Wednesday, November 10, 2021
Omaha World-Herald: UNMC researchers develop 'molecular scissors' to target HIV
Researchers at the University of Nebraska Medical Center have used a new method they’re calling a “molecular scissors” to nearly eliminate HIV embedded in the genetic material of human cells.
Thursday, November 04, 2021
University of Maryland School of Medicine Institute of Human Virology Researchers Receive $6.5M to Create African Big Data Hub Designed to Address Public Health and Pandemic Preparedness
Researchers at the University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV), a Global Virus Network (GVN) Center of Excellence, have received $6.5 million from the U.S. National Institutes of Health (NIH) to streamline big data collection in Nigeria and South Africa in addressing public health needs of the COVID-19 and HIV pandemics.
Tuesday, July 06, 2021
UM School of Medicine Researchers Receive NIH Avant-Garde Award for Out-Of-Box Concept to Cure HIV and Treat Co-Existing Addiction
Linda Chang, MD, MS, Professor of Diagnostic Radiology & Nuclear Medicine at the University of Maryland School of Medicine (UMSOM), received the National Institute on Drug Abuse (NIDA) 2021 Avant-Garde Award (DP1) for HIV/AIDS and Substance Use Disorder Research, a National Institutes of Health (NIH) Director’s Pioneer Award. This prestigious award supports researchers with exceptional creativity, who propose high-impact research with the potential to be transformative to the field. She will work with Institute for Human Virology (IHV) researchers for this project.
Monday, June 07, 2021
POZ: Integrate Adult and Pediatric HIV Care to Ease Youth Transition to Adult Care
Embedding an adult HIV medicine clinician and care navigator into a Baltimore pediatric HIV clinic led to 95% of young people remaining engaged in adult care one year after transition, according to a report in AIDS Care.
Thursday, May 27, 2021
Baltimore Sun: Maryland researchers study whether HIV cure can come from infusing patients with genetically modified ‘super T cells’
A week ago, a Washington, D.C., man in his 30s with HIV became the first person to be infused with a heaping load of his own genetically modified cells that a Maryland biotech firm believes one day could lead to the elusive cure for the disease. American Gene Technologies’ method involves taking T cells out of a person’s blood and genetically modifying them in the lab to resist infection before they are reinfused. C. David Pauza is the company’s chief science officer and a former professor and researcher at the University of Maryland School of Medicine’s Institute for Human Virology. Another center evaluating entering the study is Maryland’s Institute for Human Virology, confirmed its co-founder and director, Dr. Robert Gallo, who is internationally regarded for his role in discovering HIV and developing a blood test to detect it.
Thursday, April 01, 2021
A Statement from the Leadership of the University of Maryland School of Medicine’s Institute of Human Virology on the Passing of Dr. John Martin
The Institute of Human Virology at the University of Maryland School of Medicine mourns the passing of IHV 2014 Lifetime Achievement Public Service Awardee and 2017 Annual Marlene and Stewart Greenebaum Lecturer, John Martin, PhD. Dr. Martin was a leader in supporting access to life-saving anti-HIV medications that although still under patent were made widely and affordably available to millions around the world infected with HIV, and for prevention through pre-exposure drug therapy. He was a tremendous clinical scientist, businessman, global public health leader, philanthropist, and good friend.
Monday, August 03, 2020
Infectious Disease Special Edition: COVID-19 and HIV: Was It a Deadly Mix?
Social distancing is one of the curses of COVID-19, and may fall more heavily on people with HIV than on those without this burden. “People with HIV, and in particular certain subsets of that group—the LGBTQ community, older adults aging with HIV, etc.—face more mental health issues than the general population,” said Sarah Schmalzle, MD, an assistant professor of medicine at the Institute of Human Virology, University of Maryland School of Medicine, in Baltimore. “Many of our patients also already face significant isolation and loneliness due to a combination of HIV stigma, losses of friends and family to HIV, and aging.”
Tuesday, July 07, 2020
Courthouse News Service: Global Progress on Ending HIV/AIDS Derailed by Covid-19
A United Nations program aimed at eliminating HIV/AIDS released a report Monday showing that the global response to the epidemic has fallen far short of goals set for 2020, in large part due to the coronavirus pandemic.
Saturday, April 11, 2020
Institute of Human Virology Honors Legacy of Maeve Kennedy McKean With Global Public Health Fellowship
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today the Maeve Kennedy McKean Global Public Health Fellowship, named in honor of the public health activist, whose inspiring life ended tragically alongside her oldest son last week. The first fellow will arrive on July 1 and will work on the Institute’s efforts in ending the HIV epidemic in Africa within its Center for International Health, Education, and Biosecurity (CIHEB) and Division of Clinical Care and Research.
Thursday, October 17, 2019
A Statement from the Leadership of the Institute of Human Virology on the Passing of The Honorable Elijah Cummings
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine mourns the passing of The Honorable Elijah Cummings, a lifelong Baltimorean, a member of the U.S. House of Representatives representing Maryland’s 7th District, and, among other prominent positions, a member of IHV’s Board of Advisors.
Wednesday, May 01, 2019
Large National Survey Shows Smaller HIV Epidemic in Nigeria Than Once Thought and Highlights Key Gaps
(CDC) The Government of Nigeria, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC, and the University of Maryland School of Medicine released new data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), one of the largest population-based HIV/AIDS household surveys ever conducted. The NAIIS directly measured HIV prevalence and viral load suppression. According to the NAIIS results, the HIV prevalence in Nigeria is lower than previously thought, allowing the country to focus on providing services to the areas of greatest need to control the HIV epidemic.
Wednesday, March 06, 2019
UMSOM Researcher Elected as Fellow to American Academy of Microbiology
Richard Y. Zhao, Ph.D., Professor of Pathology and Associate Member of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), has been elected as a Fellow to the American Academy of Microbiology (AAM). AAM is an honorific leadership group within the American Society for Microbiology (ASM).
Tuesday, December 11, 2018
Institute of Human Virology's Shyam Kottilil to Receive National Award from American College of Physicians
The American College of Physicians announced that Shyam Kottilil, MBBS, PhD, FACP, Professor of Medicine and Director of the Division of Clinical Care and Research at the Institute of Human Virology (IHV) of the University of Maryland School of Medicine (UMSOM) and Chief of the Division of Infectious Diseases, was awarded the American College of Physicians (ACP) Richard and Hinda Rosenthal Award #1 from the Rosenthal Family Foundation.
Tuesday, December 04, 2018
Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.
Monday, December 03, 2018
Institute of Human Virology Names Dr. Man Charurat as Director of the Center for International Health, Education, and Biosecurity
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine today announced the appointment of Man E. Charurat, PhD, MHS, Professor of Medicine and Director of the Division of Epidemiology and Prevention at the IHV as the Director of IHV’s Center for International Health, Education, and Biosecurity (CIHEB). Dr. Charurat will replace Deus Bazira, DrPH, MPH, MBA. The announcement was made by Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the IHV, and Co-Founder and Director of the Global Virus Network (GVN).
Tuesday, October 23, 2018
Institute of Human Virology Hosts 20th Annual International Meeting of Top Medical Virus Researchers in Baltimore, Maryland
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine yesterday commenced IHV’s 20th Annual International Meeting, to be held through Thursday, October, 25 at the Four Seasons Hotel in Baltimore, Maryland. This year, among other viral and cancer related topics, the meeting is holding special sessions on the 40th anniversary of the first human retrovirus, Human T cell Leukemia Virus (HTLV), and the 15th anniversary of the President’s Emergency Plan for AIDS Relief (PEPFAR). IHV’s Annual International Meeting attracts hundreds of elite scientists who descend upon Baltimore to share ideas and inspire medical virus research collaborations.
Wednesday, August 02, 2017
UM School of Medicine Receives $2 Million Grant for HIV Research in Malawi
The University of Maryland School of Medicine’s (UM SOM) Institute for Global Health (IGH) and the Institute of Human Virology (IHV) have been awarded a $2 million five-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the impact exposure to HIV has on the immune systems of infants in utero and how those changes impact the ability of infants to fight off infections after birth.
Tuesday, November 22, 2016
IHV Awarded $138M to combat HIV/AIDS in Africa & Launches Center for International Health, Education, & Biosecurity
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today more than $138 million in multiple five-year grants awarded by the Centers for Disease Control and Prevention to combat HIV/AIDS in Kenya, Tanzania, Zambia, and Nigeria. The Institute concurrently announced the formation of the IHV Center for International Health, Education, & Biosecurity (CIHEB), and its newly appointed director, Deus Bazira Mubangizi, DrPH, MBA, MPH, Assistant Professor of Medicine, Director, Center for Health, Education, & Biosecurity, Institute of Human Virology, University of Maryland School of Medicine.
Tuesday, October 25, 2016
"A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post
As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.